A generic brand of anti-anxiety medication Xanax has been recalled. Mylan Pharmaceuticals is voluntarily recalling one lot of the Alprazolam, a Xanax generic prescription drug.A link has been sent to your friend's email address. Copyright © 2020 NBC Universal Inc. All rights reserved is 8082708 and it has a September 2020 expiration date.Mylan Pharmaceuticals is voluntarily recalling one lot of the prescription anti-anxiety drug Alprazolam nationwide because of “the potential presence of a foreign substance.”According to the recall notice, Mylan has notified its distributors and customers about the recall by letter and is arranging for return of all recalled products. The recall is for Alprazolam 0.5 mg tablets that were distributed in July and August 2019 in 500-count bottles. The lot number for the affected products is 8082708.The company said that while the "clinical impact" of the foreign substance, if present, is expected to be rare, "the remote risk of infection to a patient cannot be ruled out. ET, or at According to the company, Alprazolam tablets "are indicated for the management of anxiety disorder, the short-term relief of symptoms of anxiety, and the treatment of panic disorder, with or without agoraphobia." The voluntary recall includes a single lot of bottles, each containing 500 0.5-milligram tablets, that were distributed in the United States between July and August. Avoid excessive sun exposure or artificial ultraviolet light while receiving doxycycline. Wear sun protective clothing and use an SPF50+ sunscreen when outside if exposure to sunlight is unavoidable. The adulterating substance, which was only identified as a ‘foreign substance’, led to a voluntary recall from the consumer level of one lot of alprazolam tablets 0.5mg. Seek medical advice if skin redness or skin eruptions develop.
Mylan Pharmaceuticals is voluntarily recalling one lot of the anti-anxiety prescription drug Alprazolam nationwide because of “the potential presence of a foreign substance,” according to a recall notice posted on "Clinical impact from the foreign material, if present, is expected to be rare, but the remote risk of infection to a patient cannot be ruled out," the notice states. Published 8:14 p.m. Let friends in your social network know what you are reading aboutCheck your medicine cabinets. Big Ten Changes Course, Will Play Fall Football After All Related tags: Recall, Mylan, Alprazolam A voluntary recall of one lot of alprazolam tablets was announced by Mylan, after the potential presence of contaminant was discovered.
"To date, Mylan has not received any adverse events related to this batch. Retailers are being asked to contact consumers to explain the return process.To return the Alprazolam, consumers should call Stericycle at 888-843-0255.
The recall of the tablets only affects a single batch, according to the company. Consumers with questions should call Mylan at 800-796-9526, Monday through Friday, 8 a.m. to 5 p.m. Eastern time, or email at The medicine is for the management of anxiety disorder, the short-term relief of symptoms of anxiety, and the treatment of panic disorder, with or without agoraphobia, according to Mylan.© 2020 USA TODAY, a division of Gannett Satellite Information Network, LLC.Read or Share this story: https://www.usatoday.com/story/money/2019/10/28/xanax-recall-2019-mylan-pharmaceuticals-recalls-one-lot-alprazolam/2491735001/ A nationwide recall of one lot of Xanax was issued because the tablets might contain a foreign substance.. Mylan Pharmaceuticals issued a nationwide voluntary recall of one lot of alprazolam — the generic equivalent for anti-anxiety drug Xanax — tablets due to the potential presence of a foreign substance, The recall is being carried out due to the potential presence of an unspecified "foreign substance," Mylan said in its The recall affects a single batch of 0.5 mg alprazolam tablets, packaged in bottles of 500, that was distributed in the United States between July 2019 and August 2019.